πŸš€ Pharmidex In Silico Drug Discovery – The Complete Pipeline! πŸ§¬πŸ’»
February 28, 2025

At Pharmidex, we bring cutting-edge computational, structural, and molecular biology expertise to accelerate drug discovery and development. Whether you know your protein target and need to find a drug or have drug candidates and need to identify their target, our comprehensive in silico pipeline ensures success.

✨ Why Choose Pharmidex?
βœ… Gold-standard software for precision modeling
βœ… Hit and binding site identification for target validation
βœ… Library mining, extraction, and de novo design
βœ… 2D & 3D ligand-based modeling for enhanced screening
βœ… Pathway exploration and molecular dynamics analysis
βœ… X-ray crystallography & Cryo-EM structure refinement

From target determination to lead optimization, we streamline your drug discovery journey with advanced AI-driven solutions and deep scientific expertise.

πŸ“½οΈ Watch our latest video (5/5) showcasing how Pharmidex transforms drug discovery through computational innovation!

πŸ“© Let’s collaborate and push the boundaries of pharmaceutical innovation together!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. πŸ‘©‍πŸ”¬ πŸ‘¨‍πŸ”¬ Welcome to the team, Gabrielle and Mohammed!
BATA Taste Aversion
July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: βœ… Bitter-tasting APIs βœ… Unpalatable excipients βœ… The success of taste-masking strategies βœ… Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
More Posts